Peter Rahfeld

Biochemist utilizing CAZymes for human health.
| @AvivoBio | @withlabb | @UBCMSL |

[Carlo Alfieri @carlo_alfieri]

Great talk by @PRahfeld at the #ATC2023SanDiego about ABOi #kidney #transplant. Let's act of the donor and not on the recipient!

[Lizzie Aby, MD @LizzieAbyMD]

@PRahfeld of @ubcmsl / @AvivoBio presents fascinating data on proof of concept for blood group conversion for human kidneys using ex-vivo machine perfusion at #ATC2023SanDiego

[Andrew Bentall @AJBentall]

Conversion of kidneys to be universal donors. @PRahfeld #ATC2023SanDiego
Future opinions for solid organ transplantation @AvivoBio

[SynBioNL @SynBio_NL]

Dreaming of a green 🌍💚 and bright future ? ☘️ 🦠🧫

Listen to a new episode of #Benchtalks featuring #SarahDAdamo and @IrmischSandra and dive into the how, what, why of engineering green life using #synbio.

🎙️Link: https://t.co/jolAnxvfs0

[Universität Halle (inaktiv) @UniHalle]

Halle – Vancouver – Leiden. 🛫  #MLU-Alumnus Dr. @prahfeld hat nach seinem Biochemie-Studium an der Uni Halle in Kanada ein Biotech-Unternehmen mitgegründet, das der 37-Jährige heute aus den Niederlanden leitet. https://t.co/5Cg5Llb1Og

[UBC Science @ubcscience]

#UBC researchers have developed a process that could make #blood types obsolete.

@JayKizLab @CBR_UBC @UBCChem @ubcmsl @PRahfeld @withlabb

#BloodResearch #HealthResearch #transplant #BloodTransfusion

https://t.co/n9xr8VK3ze

[Life Sciences BC @lifesciences_bc]

@AvivoBio is seeking a Technician, Process Development to support the development of upstream and downstream processes, as well as impurity assay development to support the ongoing development of bacterial-produced enzyme-based product. Link: https://t.co/5leYFSO6yL

[Avivo Biomedical Inc. @AvivoBio]

ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: https://t.co/1HhlFavdR2 and be sure to play the video on the homepage.

[Avivo Biomedical Inc. @AvivoBio]

We’re hiring! We are looking for a Project Manager and a Technician to join us on our journey to make blood types obsolete for blood transfusions and organ transplants. Postings listed at the @lifesciences_bc job board https://t.co/uu5wyprgRY

[GlycoNet @glyconet_nce]

Haiming Luo from @UBC presenting on engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection.
#CGSBanff #glycotime @JayKizLab

[Rhea Bains @rheabains]

Daniel Luo from @JayKizLab talks about engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection!!! #glycotime

[Peter Rahfeld @PRahfeld]

Lars Kruse @the_real_larsk @BohlmannLab did present latest results on the production of Montbretin A, a anti-diabetic compound, at the GlycoNet Symposium @glyconet_nce. Great Talk !
#CGSBanff

[Rhea Bains @rheabains]

Our review on Carbohydrate-active enzymes in the gut microbiome is live! @withlabb @jacobwardman1 @PRahfeld #glycotime

[Jacob Wardman @jacobwardman1]

So happy to get this review out with @rheabains @PRahfeld @withlabb! Move over hot girl summer, it's Carbohydrate-Active Enzyme spring 🤓!

[GlycoNet @glyconet_nce]

Understanding how sugars (glycans) influence blood type and organ donor compatibility is enabling incredible innovations in #health. Exciting work from GlycoNet researchers @withlabb @JayKizLab @PRahfeld @LjwestWest & others.
#glycotime #glycomics

[UBC Centre for Blood Research @CBR_UBC]

🅾️A new study shows it's possible to convert #blood type safely in donor organs intended for #transplantation.

Dr. Jayachandran Kizhakkedathu (@JayKizLab) - as well as collaborators @PRahfeld, @withlabb, & many others - are part of this exciting work.

https://t.co/z7HWcxoekP

[Sandra Irmisch @IrmischSandra]

PhD vacancy, 1 week left to apply! Come and work with us on this beautiful plant, below ground even more fascinating. Details here: https://t.co/Grqkbxo1nd

#PlantSciJobs #PlantScience #PhDposition #vacancy @LeidenBiology @UniLeiden

[John Barclay @johnbarclayiii]

Looking forward to virtually attending and presenting on behalf of @ABOzymes!

[Sandra Irmisch @IrmischSandra]

VACANCY: Fully funded PhD position in my lab. Fascinated by plant specialized metabolism? Come and work with us! #PlantScience #PlantSciJobs @LeidenBiology @UniLeiden
-> study regulation and transport of a novel anti-diabetic plant derived metabolite https://t.co/sKDztGDglI

[GlycoNet @glyconet_nce]

GlycoNet's Dr. Stephen Withers @UBC is leading Phase 1 trial of a new anti-diabetic compound. By slowing starch breakdown, it could be used to help manage Type 2 #diabetes w/ fewer side effects than other treatments.
Read more: https://t.co/xmqzoaoLIz
#WorldDiabetesDay #Glycomics